EU regulator evaluating use of Pfizer’s vaccine for younger children

According to World Economic Forum, the European Medicines Agency is evaluating the use of the Pfizer/BioNTech COVID-19 vaccine in children as young as five.

Last week Pfizer released data that supports the use of their mRNA vaccine for children between the ages of five and 11 years.

Click here to read more.

Articles You Might Like

Share This Article

Share on facebook
Share on twitter
Share on linkedin
Share on tumblr